Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-30

FDA Approved: BICALUTAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sun Pharmaceutical's Bicalutamide, resulting in updated labeling for this generic antiandrogen. The drug is used in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bicalutamide (bicalutamide)

Snippet

SUPPL AP for BICALUTAMIDE (BICALUTAMIDE)